Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when UHS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsUHS adds up to $700M delayed draw term loan facility, available through Sept 2026
Filed July 21, 2026 · Period ending July 20, 2026 · ~1 min read
Key Changes
-
high
UHS amended its credit agreement to add a $700M delayed draw term loan facility, expanding available liquidity and borrowing capacity under its senior secured credit facility.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
The facility is available for drawdown through September 30, 2026, with any borrowed amounts maturing 364 days after funding and no amortization required.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
UHS must prepay outstanding amounts if it incurs certain new debt or issues equity, subject to limited exceptions, ensuring the facility is repaid if other capital sources are accessed.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
Initial pricing is SOFR/Term Benchmark +, with the margin tied to the company's leverage ratio.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
Proceeds are intended for general corporate purposes, including refinancing existing debt and paying related fees and expenses.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
Summary
Universal Health Services has secured a $700 million delayed draw term loan facility through an amendment to its existing senior secured credit agreement. The facility provides UHS with additional liquidity that can be tapped through the end of September 2026, with any borrowed amounts due 364 days after drawdown.
The company intends to use proceeds for general corporate purposes, including refinancing existing debt. For retail investors, this filing signals UHS is proactively managing its capital structure and ensuring access to liquidity.
The short availability window (through September 2026) and one-year maturity suggest the company may be addressing near-term debt maturities or positioning itself for operational flexibility. The mandatory prepayment provision if UHS raises other capital indicates this is bridge financing rather than permanent debt. The pricing at SOFR + reflects current market conditions for investment-grade healthcare operators. This is a routine treasury management action that expands the company's financial flexibility without immediate balance sheet impact unless drawn.
Section-by-Section Diff
Event · Item 2.03 — Creation of a Direct Financial Obligation
Item 2.03 also reports this as a direct financial obligation (body incorporates the primary Item by reference).
Added in current filing · verify on EDGAR →
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth in response to Item 1.01 under the heading “Senior Secured Credit Facility” is incorporated by reference into this Item 2.03.
The company also filed this under Item 2.03, which means it is reporting the arrangement as a direct financial obligation. The Item 2.03 text refers back to the Item 1.01 entry for the terms rather than restating them.
Event · Item 1.01 — Entry into a Material Definitive Agreement
Item 1.01 — Entry into a Material Definitive Agreement filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
The July 2026 Delayed Draw Term Loan, in an aggregate principal amount of up to $700 million, is available to be drawn down by the Company during the period from July 20, 2026 through September 30, 2026, and will mature on the date that is 364 days after the date of funding of the July 2026 Delayed Draw Term Loan (the “Maturity Date”). The July 2026 Delayed Draw Term Loan shall not amortize, and any outstanding amounts thereunder shall be payable in full on the Maturity Date
The facility is available for drawdown through September 30, 2026, and any amounts borrowed will mature 364 days after funding with no amortization. This provides UHS with short-term financing flexibility over the next few months, with repayment due approximately $700 million one year after any draw.
Added in current filing · verify on EDGAR →
If the Company draws upon the July 2026 Delayed Draw Term Loan, it intends to use the proceeds for general corporate purposes, including the refinancing of existing indebtedness and the payment of fees and expenses in connection therewith.
UHS plans to use any proceeds from the facility for general corporate purposes, including refinancing existing debt. This suggests the company may be managing near-term debt maturities or optimizing its capital structure.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 22, 2026 · How we verify